JRKL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.725800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.921200E-01
Normal-vs-Stage2
9.630200E-01
Normal-vs-Stage3
1.158230E-01
Normal-vs-Stage4
6.199600E-01
Stage1-vs-Stage2
9.600600E-01
Stage1-vs-Stage3
7.963600E-02
Stage1-vs-Stage4
4.862600E-01
Stage2-vs-Stage3
6.501700E-02
Stage2-vs-Stage4
2.308000E-01
Stage3-vs-Stage4
1.397560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.630200E-01
Normal-vs-AfricanAmerican
8.286000E-01
Normal-vs-Asian
9.264800E-01
Caucasian-vs-AfricanAmerican
9.799800E-01
Caucasian-vs-Asian
9.187400E-01
AfricanAmerican-vs-Asian
9.352400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.397600E-01
Normal-vs-Female
7.922000E-01
Male-vs-Female
4.909200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.834800E-01
Normal-vs-Age(41-60Yrs)
7.245200E-01
Normal-vs-Age(61-80Yrs)
7.071400E-01
Normal-vs-Age(81-100Yrs)
6.157000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.070200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.690600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.575600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.014010E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.155000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.084600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.488800E-01
Normal-vs-Daily Drinker
6.106600E-01
Normal-vs-Weekly Drinker
4.944400E-01
Normal-vs-Occasional Drinker
9.882600E-01
Normal-vs-Social Drinker
9.972000E-01
Non Drinker-vs-Daily Drinker
4.847000E-01
Non Drinker-vs-Weekly Drinker
4.650200E-01
Non Drinker-vs-Occasional Drinker
6.670600E-01
Non Drinker-vs-Social Drinker
6.898400E-01
Daily Drinker-vs-Weekly Drinker
9.415000E-01
Daily Drinker-vs-Occasional Drinker
2.870200E-01
Daily Drinker-vs-Social Drinker
2.899400E-01
Weekly Drinker-vs-Occasional Drinker
2.395600E-01
Weekly Drinker-vs-Social Drinker
1.959820E-01
Occasional Drinker-vs-Social Drinker
9.720800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.852400E-02
Normal-vs-Grade 2
6.158700E-03
Normal-vs-Grade 3
6.180400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.987000E-04
Grade 1-vs-Grade 3
1.821260E-04
Grade 1-vs-Grade 4
9.852400E-02
Grade 2-vs-Grade 3
1.872610E-01
Grade 2-vs-Grade 4
6.158700E-03
Grade 3-vs-Grade 4
6.180400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.174600E-01
Normal-vs-NonDiabetic
9.052400E-01
Diabetic-vs-NonDiabetic
5.965500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.562200E-01
Normal-vs-NoPancreatitis
7.786000E-01
Pancreatitis-vs-NoPancreatitis
2.841800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.040200E-01
Normal-vs-N1
9.379800E-01
N0-vs-N1
5.411400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.935200E-01
Normal-vs-TP53-NonMutant
6.974000E-01
TP53-Mutant-vs-TP53-NonMutant
2.07409999999353E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
